Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2009
11/26/2009CA2724785A1 Selective caspase inhibitors and uses thereof
11/26/2009CA2724653A1 Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
11/26/2009CA2724592A1 Agent for maintenance of induced remission
11/26/2009CA2724569A1 Compositions and methods to protect cells by blocking entry of pathogen proteins
11/26/2009CA2724562A1 Novel dual targeting antitumoural conjugates
11/26/2009CA2724527A1 Vegf165 delivered by fibrin sealant to reduce tissue necrosis
11/26/2009CA2720729A1 Novel macrocyclic inhibitors of hepatitis c virus replication
11/26/2009CA2667177A1 Slpa as a tool for recombinant protein and enzyme technology
11/25/2009EP2123759A2 Stabilized RNAS as transfection controls and silencing reagents
11/25/2009EP2123751A1 Novel peptide
11/25/2009EP2123748A1 2'-5'-oligoadenylate synthetase 3 for preventing and treating positive-sense single-stranded rna virus infection
11/25/2009EP2123680A1 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof
11/25/2009EP2123678A1 Identifying acceptor germline sequences for humanized antibodies
11/25/2009EP2123674A1 Treatment of fibrosis by antagonism of IL-13 and/or IL-13 receptor
11/25/2009EP2123672A1 Modulation of IL-2- and IL-15- mediated T cell responses
11/25/2009EP2123671A1 Immunogenic peptide composition for the prevention and treatment of Alzheimer's Disease
11/25/2009EP2123669A1 Copolymers for suppression of autoimmune diseases, and methods of use
11/25/2009EP2123666A1 Peptide
11/25/2009EP2123665A2 Inhibitors of interleukin-1Beta converting enzyme
11/25/2009EP2123328A1 Galanthamine derivatives, methods for their obtaining and use
11/25/2009EP2123295A1 Therapeutic agent for interstitial pneumonia
11/25/2009EP2123294A1 Food ingredients and food products treated with an oxidoreductase and methods for preparing such food ingredients and food products
11/25/2009EP2123293A2 Peptide YY and petide YY agonists for treatment of metabolic disorders
11/25/2009EP2123292A1 Angiogenically effective unit dose of FGF-2 and method of use
11/25/2009EP2123283A1 The tetracyclic anthraquinones possessing anti-cancer effect
11/25/2009EP2123259A1 Liposome preparation for iontophoresis having antioxidant component encapsulated therein
11/25/2009EP2123256A1 Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
11/25/2009EP2121931A1 Purification of fc-tact fusion proteins using the oilbody technology
11/25/2009EP2121930A1 Neurotrophic peptides
11/25/2009EP2121749A1 Recombinant gelatins
11/25/2009EP2121742A2 Metastasis-specific peptides and their diagnostic and therapeutic applications
11/25/2009EP2121736A1 New anti-malaria vaccine compositions and uses thereof
11/25/2009EP2121729A1 Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture
11/25/2009EP2121728A1 Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl- d-tryptophan
11/25/2009EP2121727A1 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan
11/25/2009EP2121057A1 Polymerization with precipitation of proteins for elution in physiological solution
11/25/2009EP2121034A1 Use of sirt7 for treating age-related diseases
11/25/2009EP2121023A1 Controlled release composition and process
11/25/2009EP2121017A2 Method for inhibiting the expression of endogenous erythropoietin (epo)
11/25/2009EP2121006A1 Intraperitoneal administration of antithrombin iii, related compositions and methods
11/25/2009EP2121005A1 Treatment of fabry disease
11/25/2009EP2121004A2 Obligate heterodimer meganucleases and uses thereof
11/25/2009EP2121001A2 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
11/25/2009EP2121000A2 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury
11/25/2009EP2120999A2 Activin-actriia antagonists and uses for promoting bone growth in cancer patients
11/25/2009EP2120998A2 Modified erythropoietin polypeptides and uses thereof for treatment
11/25/2009EP2120997A2 Modulation of activity of proneurotrophins
11/25/2009EP2120996A2 Methods for using and identifying modulators of delta-like 4
11/25/2009EP2120995A2 The secreted protein ccdc80 regulates adipocyte differentiation
11/25/2009EP2120994A2 Methods and compositions for treating hypoglycemic disorders
11/25/2009EP2120993A1 Novel use of hiv nc protein
11/25/2009EP2120992A1 Use of platelet glycopeptide iiia epitopes in the treatment of immune thrombocytopenic purpura
11/25/2009EP2120991A1 Treatment of trauma hemorrhage with short oligopeptides
11/25/2009EP2120990A1 Reducing post-operative adhesion formation with intraperitoneal glutamine
11/25/2009EP2120988A1 Treating hepatitis c virus infection
11/25/2009EP2120987A1 Treating stroke and other diseases without inhibiting n-type calcium channels
11/25/2009EP2120985A2 Compositions and methods for treating psychiatric diseases and disorders
11/25/2009EP2120984A2 Protective proteins of s. agalactiae, combinations thereof and methods of using the same
11/25/2009EP2120983A2 Novel anti-microbial peptidomimetic compounds and methods to calculate anti-microbial activity
11/25/2009EP2120982A1 Polypeptides having modulatory effects on cells
11/25/2009EP2120912A1 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor
11/25/2009EP2120894A1 Oral submicron particle delivery system for proteins and process for its production
11/25/2009EP2120893A1 Protein-containing substance with increased thermal stability
11/25/2009EP2120892A1 A lactase formulation
11/25/2009EP2120876A2 Nanoparticle delivery systems for membrane-integrating peptides
11/25/2009EP2120869A2 Human growth hormone formulations
11/25/2009EP2120859A2 Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents
11/25/2009EP1776099B1 Methods for improving bioavailability of a renin inhibitor
11/25/2009EP1729788B1 Restenosis therapy using mesenchymal stem cells
11/25/2009EP1658373B1 Co-expression vector for the membrane domains of viral envelope proteins and uses thereof
11/25/2009EP1653994B1 Use of cxcl6 chemokine in the prevention or repair of cartilage defects
11/25/2009EP1599595B1 N -acetylglucosaminyltransferase iii expression in lower eukaryotes
11/25/2009EP1268509B1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
11/25/2009EP1210108B1 Use of leptin together with an inhibitor of vegf and/or an inhibitor of angiogenesis for the inhibition of endothelial cell proliferation
11/25/2009EP1019490B1 Methods for modulating hematopoiesis and vascular growth
11/25/2009EP0954585B1 Human telomerase reverse transcriptase promoter
11/25/2009CN101589309A Methods for screening and treatment involving the genes GYPC, AGPAT3, AGL, PVRL2, HMGB3, HSDL2 and/or LDB2
11/25/2009CN101589145A Modified soluble FGF receptor Fc fusions with improved biological activity
11/25/2009CN101589060A Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
11/25/2009CN101589056A Depsipeptides and their therapeutic use
11/25/2009CN101588820A Alpha-lactalbumin composition
11/25/2009CN101588812A Specific therapy and medicament using integrin ligands for treating cancer
11/25/2009CN101588811A Fluidized spray drying
11/25/2009CN101588809A Fermented milk for improving and/or treating skin and method for producing the same
11/25/2009CN101588762A Device for removing blood clots from blood vessels
11/25/2009CN101586142A Research approach for element for forcing knubble microenvironment and application thereof
11/25/2009CN101586096A Recombinant virus with coexpression of anthropogenic glutamate decarboxylase and cell factor
11/25/2009CN101585868A Method for extracting natural colorant glycoprotein of eucheuma
11/25/2009CN101585866A Polypeptide for regulating activity of FGFR3 and screening method and application thereof
11/25/2009CN101585864A Nitrogen-terminal fixed-point coupling method for colony stimulating factor of column chromatography granulocyte and coupled product
11/25/2009CN101584868A Application of NPTX gene on preparation of antineoplastic medicaments
11/25/2009CN101584867A Methods and compositions for enhanced delivery of bioactive molecules
11/25/2009CN101584866A Polyethylene glycol modified human interleukin-2, preparation method and application thereof
11/25/2009CN101584862A Diagnosing tumorigenicity and determining resistance to anticancer therapy
11/25/2009CN101584859A Orally-taken hirudin microsphere preparation and preparation method thereof
11/25/2009CN101584858A Stable protein formulations
11/25/2009CN101584857A Ophthalmic preparation and preparation method thereof
11/25/2009CN101584856A Medicament of treating ophthalmic disease
11/25/2009CN101584855A Pharmaceutical preparation and preparation method thereof
11/25/2009CN101584854A Romurtide cyclodextrin inclusion compound, preparation thereof and method for preparing same
1 ... 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 ... 3163